Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
New England Journal of Medicine · 02.11.2023 · 389 (18) · 1672-1684
DOI: 10.1056/nejmoa2304875 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 02.11.2023. Verfasst von John V Heymach und 27 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Thoracic-Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (J.V.H.), and US Oncology Re…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Immunological, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 810-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: AstraZeneca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Thoracic-Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (J.V.H.), and US Oncology Research, the Woodlands (A.S.) - both in Texas; the Department of Surger…
ORCID-Profile: Bivas Biswas
Förderung
- AstraZeneca
Zitieren
APA
Heymach, J. V., Harpole, D., Mitsudomi, T., Taube, J. M., Galffy, G., Hochmair, M., Winder, T., Zukov, R., Garbaos, G., Gao, S., Kuroda, H., Ostoros, G., Tran, T. V., You, J., Lee, K. Y., Antonuzzo, L., Papai-Szekely, Z., Akamatsu, H., Biswas, B., …, & AEGEAN Investigators (2023). Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer. New England Journal of Medicine, 389(18), 1672-1684. https://doi.org/10.1056/nejmoa2304875
Vancouver
Heymach JV, Harpole D, Mitsudomi T, Taube JM, Galffy G, Hochmair M, et al. Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer. New England Journal of Medicine. 2023;389(18):1672-1684. doi:10.1056/nejmoa2304875
BibTeX
@article{Heymach2023,
author = {Heymach, John V and Harpole, David and Mitsudomi, Tetsuya and Taube, Janis M and Galffy, Gabriella and Hochmair, Maximilian and Winder, Thomas and Zukov, Ruslan and Garbaos, Gabriel and Gao, Shugeng and Kuroda, Hiroaki and Ostoros, Gyula and Tran, Tho V and You, Jian and Lee, Kang-Yun and Antonuzzo, Lorenzo and Papai-Szekely, Zsolt and Akamatsu, Hiroaki and Biswas, Bivas and Spira, Alexander and Crawford, Jeffrey and Le, Ha T and Aperghis, Mike and Doherty, Gary J and Mann, Helen and Fouad, Tamer M and Reck, Martin and AEGEAN Investigators, AEGEAN Investigators},
title = {Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer},
journal = {New England Journal of Medicine},
year = {2023},
volume = {389},
number = {18},
pages = {1672--1684},
doi = {10.1056/nejmoa2304875}
}
EUVIMED